Last reviewed · How we verify
NCT04764578
Sexual Dysfunction Following Upper Extremity Trauma
trial in Sexual Dysfunction. Withdrawn.
26 October 2022
Quick facts
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 March 2022 |
| Primary completion | 26 October 2022 |
| Estimated completion | 26 October 2022 |
Conditions studied
- Sexual Dysfunction — all drugs for Sexual Dysfunction →
- Upper Extremity Trauma — all drugs for Upper Extremity Trauma →
Sponsor
Vanderbilt University Medical Center
Who can join
18 and older, any sex, with Sexual Dysfunction or Upper Extremity Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypothesis 1. The prevalence of sexual dysfunction after upper extremity function in adults (\>18yo) is higher than the general population in the early post-operative period (3mo) and at 1 year post-operatively. 2. Null: Adult patients (\<18 yo) with isolated upper extremity trauma do not experience sexual dysfunction more than the general population. Primary Study Question a) What is the prevalence of sexual dysfunction after upper extremity trauma (fracture, soft tissue disruption, neurovascular injury, and completion amputation) in adult patients? Secondary Study Questions 1. Are there patient or injury factors that can predict sexual dysfunction? 2. Do certain fractures cause more sexual dysfunction than others? 3. Can we accurately predict which patients may experience sexual dysfunction post-injury?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04764578
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexual Dysfunction
Currently open trials in the same condition.
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
- NCT06541002 — A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors · NA · recruiting
- NCT06868121 — AYA OMGYES Sexual Health Study · NA · recruiting
- NCT06587841 — Noninvasive Spinal Cord Stimulation for Early SCI · NA · recruiting
Other Vanderbilt University Medical Center trials
Trials by the same sponsor.
- NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
- NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
- NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
- NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
- NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04764578 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
- Last refreshed: 8 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04764578.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing